News
STRASBURG, France and CHARLEROI, Belgium I June 11, 2025 I Elkedonia SAS, a company pioneering a novel neuroplastogen approach to develop therapeutic ...
CATANIA, Italy I June 10, 2025 I SIFI, a leading international ophthalmic company, today announced that its shareholders have signed an agreement, subject to ...
BERLIN, Germany & CAMBRIDGE, MA, USA I June 11, 2025 I Bayer and the Broad Institute today announced that they have extended their research collaboration ...
The collaboration combines Salipro Biotech's unique expertise and its Salipro® platform technology to stabilize a challenging drug target and advance ...
– Series A financing co-led by Omega Funds, Atlas Venture, Lightspeed Venture Partners, BVF Partners, and Cormorant Asset Management, with participation from other leading healthcare funds – ...
BOSTON, MA, USA and LAUSANNE, Switzerland I June 10, 2025 I Alys Pharmaceuticals, Inc. ("Alys"), an immune-dermatology focused company, today announces the ...
TUEBINGEN, Germany I June 10, 2025 I HepaRegeniX GmbH (“HepaRegeniX”), a clinical-stage company advancing novel therapies to treat acute and chronic liver ...
WASHINGTON, DC, USA I June 10, 2025 I Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced the first dose in ...
SAN DIEGO, CA, USA I June 10, 2025 I Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), an innovative, commercial-stage biopharmaceutical company dedicated to ...
FREISING, Germany I June 10, 2025 I XL-protein GmbH, a pioneer in the area of biopolymers for pharmacokinetic optimization, announced today that it has ...
PARIS, France I June 10, 2025 I As metabolic dysfunction-associated steatohepatitis (MASH) emerges as one of the most dangerous and underdiagnosed drivers of ...
MILAN, Italy I June 06, 2025 I Italfarmaco S.p.A. announced today that the European Commission (EC) has granted conditional marketing authorisation for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results